Get the latest market trends in your inbox

Stay on top of the latest market trends and economic insights with the Axios Markets newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Reps. Jim Jordan and Elijah Cummings. Photo: Mark Wilson/Getty Images

Today in strange bedfellows: The ultra-conservative House Freedom Caucus and the Congressional Black Caucus share enthusiasm for the same bill — an infrastructure package with bipartisan and pan-ideological enthusiasm.

What's more, House Minority Leader Kevin McCarthy (R-Calif.) is onboard. The Intercept's Ryan Grim summed up these unusual political dynamics in a tweet: "Here's Breitbart writing about Kevin McCarthy endorsing the use of a CBC-backed bill to make an infrastructure deal happen. Worlds are colliding."

Details: As we reported last year, the bill — called the Generating American Infrastructure and Income Now (GAIIN) Act — would require the Department of Agriculture to sell its distressed debt assets, estimated to be worth more than $50 billion.

  • The money gained by selling off these assets would be divided in two: Half would go to paying down the national debt, and half would go to funding infrastructure projects in communities below the poverty level.

In a Saturday phone interview, Wendell Stemley, the president of the National Association of Minority Contractors, told me he's backing the GAIIN Act. "Like everybody, we want to see a fully funded infrastructure bill," he said. "But one that accomplishes some of those objectives without raising the national debt and additional taxes has got to be something we get behind."

Go deeper

Cold December as safety nets expire

Illustration: Sarah Grillo/Axios

Safety nets are likely to be yanked from underneath millions of vulnerable Americans in December, as the coronavirus surges.

Why it matters: Those most at risk are depending on one or more relief programs that are set to expire, right as the economic recovery becomes more fragile than it's been in months.

14 hours ago - Health

Food banks feel the strain without holiday volunteers

People wait in line at Food Bank Community Kitchen on Nov. 25 in New York City. Photo: Michael Loccisano/Getty Images for Food Bank For New York City

America's food banks are sounding the alarm during this unprecedented holiday season.

The big picture: Soup kitchens and charities, usually brimming with holiday volunteers, are getting far less help.

17 hours ago - Health

AstraZeneca CEO: "We need to do an additional study" on COVID vaccine

Photo: Pavlo Gonchar/SOPA Images/LightRocket via Getty Images

AstraZeneca CEO Pascal Soriot said on Thursday the company is likely to start a new global trial to measure how effective its coronavirus vaccine is, Bloomberg reports.

Why it matters: Following Phase 3 trials, Oxford and AstraZeneca said their vaccine was 90% effective in people who got a half dose followed by a full dose, and 62% effective in people who got two full doses.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!